Cancer Terms

Nadolol

Cancer Terms -> Drugs and Chemicals -> Pharmacologic Substance -> Agent Affecting Nervous System -> Adrenergic Agent -> Adrenergic Antagonist -> Beta-Adrenergic Blocking Agent -> Nadolol

Nadolol Definition

A non-selective beta-adrenergic antagonist with antihypertensive and antiarrhythmic activities. Nadolol competitively blocks beta-1 adrenergic receptors located in the heart and vascular smooth muscle, therefore inhibiting the effects of catecholamines, epinephrine, and norepinephrine. As a result, this agent produces negative inotropic and chronotropic effects. Nadolol exerts its antiarrhythmic effect via impairment of atrioventricular (AV) node conduction and reduction of sinus rate. In addition, nadolol blocks beta-2 adrenergic receptors located in the bronchiole smooth muscle resulting in vasoconstriction. Furthermore, beta-2 receptor blockage within the juxtaglomerular apparatus leads to the inhibition of renin production, as well as subsequent reduction in angiotensin II and aldosterone levels, thereby inhibiting angiotensin II and aldosterone dependent vasoconstriction and water retention.

Nadolol Synonyms

Nadolol, Corgard, NADOLOL

Terms in Nadolol category



Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods

No reproduction or republication permitted.